Cargando…
Design, synthesis, biological evaluation and molecular docking studies of novel pleuromutilin derivatives containing nitrogen heterocycle and alkylamine groups
A series of pleuromutilin derivatives containing alkylamine and nitrogen heterocycle groups were designed and synthesised under mild conditions. The in vitro antibacterial activity of these semisynthetic derivatives against four strains of Staphylococcus aureus (MRSA ATCC 43300, S.aureus ATCC 29213,...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9318235/ https://www.ncbi.nlm.nih.gov/pubmed/35875944 http://dx.doi.org/10.1080/14756366.2022.2104267 |
_version_ | 1784755241869115392 |
---|---|
author | Wang, Qi Liu, Jie Zhou, Zi-Dan Zhou, Ke-Xin Li, Fei Zhang, Qi-Wen Wang, Shou-Kai Wang, Wei Jin, Zhen Tang, You-Zhi |
author_facet | Wang, Qi Liu, Jie Zhou, Zi-Dan Zhou, Ke-Xin Li, Fei Zhang, Qi-Wen Wang, Shou-Kai Wang, Wei Jin, Zhen Tang, You-Zhi |
author_sort | Wang, Qi |
collection | PubMed |
description | A series of pleuromutilin derivatives containing alkylamine and nitrogen heterocycle groups were designed and synthesised under mild conditions. The in vitro antibacterial activity of these semisynthetic derivatives against four strains of Staphylococcus aureus (MRSA ATCC 43300, S.aureus ATCC 29213, S.aureus AD3, and S.aureus 144) were evaluated by the broth dilution method. Compound 13 was found to have excellent antibacterial activity against MRSA (MIC = 0.0625 μg/mL). Furthermore, compound 13 was further studied by the time-killing kinetics and the post-antibiotic effect approach. In the mouse thigh infection model, compound 13 exhibited superior antibacterial efficacy than that of tiamulin. Meanwhile, compound 13 showed a lower inhibitory effect than that of tiamulin on RAW264.7 and 16HBE cells at the concentration of 10 μg/mL. Molecular docking study revealed that compound 13 can effectively bind to the active site of the 50S ribosome (the binding free energy = −9.66 kcal/mol). |
format | Online Article Text |
id | pubmed-9318235 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Taylor & Francis |
record_format | MEDLINE/PubMed |
spelling | pubmed-93182352022-07-27 Design, synthesis, biological evaluation and molecular docking studies of novel pleuromutilin derivatives containing nitrogen heterocycle and alkylamine groups Wang, Qi Liu, Jie Zhou, Zi-Dan Zhou, Ke-Xin Li, Fei Zhang, Qi-Wen Wang, Shou-Kai Wang, Wei Jin, Zhen Tang, You-Zhi J Enzyme Inhib Med Chem Research Paper A series of pleuromutilin derivatives containing alkylamine and nitrogen heterocycle groups were designed and synthesised under mild conditions. The in vitro antibacterial activity of these semisynthetic derivatives against four strains of Staphylococcus aureus (MRSA ATCC 43300, S.aureus ATCC 29213, S.aureus AD3, and S.aureus 144) were evaluated by the broth dilution method. Compound 13 was found to have excellent antibacterial activity against MRSA (MIC = 0.0625 μg/mL). Furthermore, compound 13 was further studied by the time-killing kinetics and the post-antibiotic effect approach. In the mouse thigh infection model, compound 13 exhibited superior antibacterial efficacy than that of tiamulin. Meanwhile, compound 13 showed a lower inhibitory effect than that of tiamulin on RAW264.7 and 16HBE cells at the concentration of 10 μg/mL. Molecular docking study revealed that compound 13 can effectively bind to the active site of the 50S ribosome (the binding free energy = −9.66 kcal/mol). Taylor & Francis 2022-07-25 /pmc/articles/PMC9318235/ /pubmed/35875944 http://dx.doi.org/10.1080/14756366.2022.2104267 Text en © 2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Paper Wang, Qi Liu, Jie Zhou, Zi-Dan Zhou, Ke-Xin Li, Fei Zhang, Qi-Wen Wang, Shou-Kai Wang, Wei Jin, Zhen Tang, You-Zhi Design, synthesis, biological evaluation and molecular docking studies of novel pleuromutilin derivatives containing nitrogen heterocycle and alkylamine groups |
title | Design, synthesis, biological evaluation and molecular docking studies of novel pleuromutilin derivatives containing nitrogen heterocycle and alkylamine groups |
title_full | Design, synthesis, biological evaluation and molecular docking studies of novel pleuromutilin derivatives containing nitrogen heterocycle and alkylamine groups |
title_fullStr | Design, synthesis, biological evaluation and molecular docking studies of novel pleuromutilin derivatives containing nitrogen heterocycle and alkylamine groups |
title_full_unstemmed | Design, synthesis, biological evaluation and molecular docking studies of novel pleuromutilin derivatives containing nitrogen heterocycle and alkylamine groups |
title_short | Design, synthesis, biological evaluation and molecular docking studies of novel pleuromutilin derivatives containing nitrogen heterocycle and alkylamine groups |
title_sort | design, synthesis, biological evaluation and molecular docking studies of novel pleuromutilin derivatives containing nitrogen heterocycle and alkylamine groups |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9318235/ https://www.ncbi.nlm.nih.gov/pubmed/35875944 http://dx.doi.org/10.1080/14756366.2022.2104267 |
work_keys_str_mv | AT wangqi designsynthesisbiologicalevaluationandmoleculardockingstudiesofnovelpleuromutilinderivativescontainingnitrogenheterocycleandalkylaminegroups AT liujie designsynthesisbiologicalevaluationandmoleculardockingstudiesofnovelpleuromutilinderivativescontainingnitrogenheterocycleandalkylaminegroups AT zhouzidan designsynthesisbiologicalevaluationandmoleculardockingstudiesofnovelpleuromutilinderivativescontainingnitrogenheterocycleandalkylaminegroups AT zhoukexin designsynthesisbiologicalevaluationandmoleculardockingstudiesofnovelpleuromutilinderivativescontainingnitrogenheterocycleandalkylaminegroups AT lifei designsynthesisbiologicalevaluationandmoleculardockingstudiesofnovelpleuromutilinderivativescontainingnitrogenheterocycleandalkylaminegroups AT zhangqiwen designsynthesisbiologicalevaluationandmoleculardockingstudiesofnovelpleuromutilinderivativescontainingnitrogenheterocycleandalkylaminegroups AT wangshoukai designsynthesisbiologicalevaluationandmoleculardockingstudiesofnovelpleuromutilinderivativescontainingnitrogenheterocycleandalkylaminegroups AT wangwei designsynthesisbiologicalevaluationandmoleculardockingstudiesofnovelpleuromutilinderivativescontainingnitrogenheterocycleandalkylaminegroups AT jinzhen designsynthesisbiologicalevaluationandmoleculardockingstudiesofnovelpleuromutilinderivativescontainingnitrogenheterocycleandalkylaminegroups AT tangyouzhi designsynthesisbiologicalevaluationandmoleculardockingstudiesofnovelpleuromutilinderivativescontainingnitrogenheterocycleandalkylaminegroups |